Skip to content
Dx

ICD-10-CM 2027 diagnosis code

E13.353Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula

Not billable — use a more specific codeRequires 7th character

E13.353 is a header code, so it can't be reported by itself. Choose one of the 4 more specific codes beneath it and add the required 7th character.Short description: Oth diab with prolif diabetic rtnop with trctn dtch n-mcla

Code last changed in FY2017 (effective October 1, 2016). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About E13.353

E13.353 is the ICD-10-CM diagnosis code for other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula. It belongs to category E13 (other specified diabetes mellitus), block E08-E13 (diabetes mellitus) and chapter 4 (endocrine, nutritional and metabolic diseases). It is a header code, so it can't be reported by itself; one of its 4 subcodes must be used instead.

Within E13.35 (other specified diabetes mellitus with proliferative diabetic retinopathy), E13.353 is specifically for other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula. Related codes cover with macular edema (E13.351), with traction retinal detachment involving the macula (E13.352), with combined traction retinal detachment and rhegmatogenous retinal detachment (E13.354), stable proliferative diabetic retinopathy (E13.355) and without macular edema (E13.359).

Codes in this range require a 7th character: 1 for right eye, 2 for left eye, 3 for bilateral and 9 for unspecified eye. Use placeholder "X" characters to fill any empty positions before the 7th character.

Use an additional code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85), insulin (Z79.4), oral antidiabetic drugs (Z79.84) and oral hypoglycemic drugs (Z79.84).

It was added in FY2017, effective October 1, 2016.

7th character

One of the following 7th characters is to be assigned to codes in subcategory E13.35 to designate laterality of the disease:

Notes that apply from higher levels

Instructions written at a parent level also apply to E13.353.

› From E13 Other specified diabetes mellitus
Includes
  • diabetes mellitus due to genetic defects of beta-cell function
  • diabetes mellitus due to genetic defects in insulin action
  • postpancreatectomy diabetes mellitus
  • postprocedural diabetes mellitus
  • secondary diabetes mellitus NEC
Excludes1
  • diabetes (mellitus) due to autoimmune process (E10.-)
  • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
  • diabetes mellitus due to underlying condition (E08.-)
  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • type 1 diabetes mellitus (E10.-)
Use additional code
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

Broader instructions also apply from Chapter 4: Endocrine, nutritional and metabolic diseases.

Alphabetic index entries

1 entries

Terms in the official ICD-10-CM index that lead to E13.353.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2017 (effective 10/1/2016): Added
  • No changes since FY2017.

Common questions about E13.353

Is E13.353 billable?

No. E13.353 is a header code. Report one of its more specific subcodes instead.